Desmarais John M 4

4 · BioRestorative Therapies, Inc. · Filed Oct 30, 2018

Form 4

Period: 2018-10-29

Director

Transactions

Award
Stock Option
2018-10-29+75,000→ 75,000 total
Exercise: $1.23Exp: 2028-10-29→ Common Stock (75,000 underlying)

Holdings

Option
Exercise: $3.73Exp: 2026-06-10→ Common Stock (35,000 underlying)
35,000
Common Stock
493,398
Option
Exercise: $4.40Exp: 2025-12-01→ Common Stock (15,000 underlying)
15,000
Warrant
Exercise: $4.00From: 2015-12-17Exp: 2020-11-17→ Common Stock (125,000 underlying)
125,000
Warrant
Exercise: $4.00From: 2016-03-18Exp: 2021-03-18→ Common Stock (250,000 underlying)
250,000
Warrant
Exercise: $4.00From: 2016-03-18Exp: 2018-12-31→ Common Stock (444,444 underlying)
444,444
Warrant
Exercise: $4.00From: 2016-03-18Exp: 2018-12-31→ Common Stock (400,000 underlying)
400,000
Warrant
(indirect: By Trust)
Exercise: $4.00From: 2016-06-30Exp: 2021-06-30→ Common Stock (40,000 underlying)
40,000
Warrant
Exercise: $4.00From: 2016-09-26Exp: 2021-09-26→ Common Stock (80,000 underlying)
80,000
Warrant
Exercise: $4.00From: 2017-02-10Exp: 2022-02-10→ Common Stock (21,731 underlying)
21,731
Warrant
Exercise: $4.00From: 2017-03-01Exp: 2022-03-01→ Common Stock (16,667 underlying)
16,667
Stock Option
Exercise: $3.35Exp: 2027-06-23→ Common Stock (125,000 underlying)
125,000

Footnotes (5)

[F1]The option vests to the extent of 5,000 shares on each of December 1, 2016, 2017 and 2018.
[F2]The option vests to the extent of 11,667 shares on each of June 10, 2016 and June 10, 2017, and 11,666 shares on June 10, 2018.
[F3]The warrant is held by a trust established by the Reporting Person for the benefit of his immediate family. The Reporting Person serves as a trustee of the trust.
[F4]The option is exercisable to the extent of 41,667 shares on each of June 23, 2017 and June 23, 2018, and 41,666 shares on June 23, 2019.
[F5]The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020.

Documents

1 file